N-Cyanoacetylurethane is used in the synthesis of inhibitors targetting the PDZ domain of PICK1, which is a potential target for brain ischemia, pain and addiction illnesses. Also it is used in the synthesis of cathespin K inhibitors.
參考文獻
Bach, A. et al.: Org. Biomol. Chem., 8, 4281 (2010); Rankovic, Z. et al.: Bioorg. Med. Chem. Lett., 20, 1488 (2010);